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Background: Meyerozyma guilliermondii (anamorph Candida guilliermondii) and Meyerozyma caribbica (anamorph
Candida fermentati) are closely related species of the genetically heterogenous M. guilliermondii complex.
Conventional phenotypic methods frequently misidentify the species within this complex and also with other
species of the Saccharomycotina CTG clade. Even the long-established sequencing of large subunit (LSU) rRNA gene
remains ambiguous. We also faced similar problem during identification of yeast isolates of M. guilliermondii
complex from indigenous bamboo shoot fermentation in North East India. There is a need for development of
reliable and accurate identification methods for these closely related species because of their increasing importance
as emerging infectious yeasts and associated biotechnological attributes.
Results: We targeted the highly variable internal transcribed spacer (ITS) region (ITS1-5.8S-ITS2) and identified seven
restriction enzymes through in silico analysis for differentiating M. guilliermondii from M. caribbica. Fifty five isolates
of M. guilliermondii complex which could not be delineated into species-specific taxonomic ranks by API 20 C AUX
and LSU rRNA gene D1/D2 sequencing were subjected to ITS-restriction fragment length polymorphism (ITS-RFLP)
analysis. TaqI ITS-RFLP distinctly differentiated the isolates into M. guilliermondii (47 isolates) and M. caribbica (08
isolates) with reproducible species-specific patterns similar to the in silico prediction. The reliability of this method
was validated by ITS1-5.8S-ITS2 sequencing, mitochondrial DNA RFLP and electrophoretic karyotyping.
Conclusions: We herein described a reliable ITS-RFLP method for distinct differentiation of frequently misidentified
M. guilliermondii from M. caribbica. Even though in silico analysis differentiated other closely related species of
M. guilliermondii complex from the above two species, it is yet to be confirmed by in vitro analysis using reference
strains. This method can be used as a reliable tool for rapid and accurate identification of closely related species of
M. guilliermondii complex and for differentiating emerging infectious yeasts of the Saccharomycotina CTG clade.
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Meyerozyma guilliermondii is a genetically heterogenous
complex belonging to the Saccharomycotina CTG clade
[1]. This complex consists of phenotypically indis-
tinguishable and closely related species namely Meyero-
zyma guilliermondii (anamorph Candida guilliermondii),* Correspondence: jeyaram.ibsd@nic.in
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reproduction in any medium, provided the orMeyerozyma caribbica (anamorph Candida fermen-
tati), Candida carpophila, Candida smithsonii, Can-
dida athensensis, Candida elateridarum and Candida
glucosophila [2-6]. Apart from its presence in healthy
human [7,8], M. guilliermondii also exists in clinical
[3,9] and environmental samples [10]. This organism
is widely studied in various aspects due to its clinical
importance, biotechnological applications and bio-
logical control potential [11].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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yeast of the non-albicans Candida (NAC) species group
which accounts for 1 – 5% of nosocomial blood stream in-
fections worldwide [9,12,13]. However, in certain geo-
graphical regions such as Brazil, India and Italy, over 10%
of all the candidaemia cases are caused by this species
[14]. The threat posed by this organism is ever increasing
due to the decreased susceptibility and emergence of
strains resistant to antifungal drugs like polyene (ampho-
tericin B) and azoles (fluconazole and itraconazole), lead-
ing to mortality in candidaemia patients [9,12,15]. C.
fermentati has been rarely found to be associated with
candidaemia [16, 17]. But due to the poor discernability of
C. fermentati from C. guilliermondii, they are commonly
misidentified in clinical laboratories. Apart from being or-
ganisms of clinical importance, M. guilliermondii and M.
caribbica are often linked with fermented foods [18-20].
M. guilliermondii is known for the production of flavour
compounds in fermented food products [21]. Further, in a
study with soybean paste fermentation, M. guilliermondii
and M. caribbica have been claimed for the efficient pro-
duction of isoflavone aglycone which is a widely known
bioactive compound for its various health promoting func-
tions [22]. M. guilliermondii is a flavinogenic yeast which
is known for the overproduction of vitamin B2 (riboflavin)
[23]. Moreover, isolates of M. guilliermondii and M. carib-
bica have exhibited great potential in the biological control
of fungi responsible for postharvest spoilage of fruits and
vegetables [24-26]. These yeast species with enhanced
biological control efficacy have emerged as a potential al-
ternative to the conventional fungicide treatment. Consid-
ering the various importance and applications of the two
species, there is a need for the development of accurate
and reliable method to identify and distinctly discriminate
the closely related species.
Current methods of yeast identification, mostly in clin-
ical practice, are mainly based on the conventional and
rapidly evolving commercial phenotypic and biochemical
methods. However, such methods are often unreliable
for accurate identification of closely related yeast species
[13,27]. According to recent studies, M. guilliermondii
and M. caribbica are extremely difficult to differentiate by
the phenotypic methods [28-31]. We also faced similar
problem during differentiation of yeast isolates from
soibum, an indigenous fermented bamboo shoot product
of North East India (Additional file 1: Table S1). The
widely used API 20 C AUX yeast identification system and
sequencing of large subunit (LSU) rRNA gene D1/D2 do-
main failed to give proper species-level taxonomic assign-
ment to these isolates (Additional file 1: Tables S2 and S3).
Moreover, the phylogenetic tree reconstructed from the
publicly available D1/D2 sequences of different strains of
M. guilliermondii and M. caribbica failed to discriminate
the two species (Additional file 2: Figure S1).Several attempts have been made using molecular ap-
proaches such as DNA base composition, electrophoretic
karyotyping [6,32], multi locus sequence typing (MLST)
[3], multi locus enzyme electrophoresis (MLEE), randomly
amplified polymorphic DNA (RAPD) [4], sequencing of
internal transcribed spacer (ITS) [28,30], intergenic spacer
restriction fragment length polymorphism (IGS-RFLP)
[29] and RFLP of housekeeping genes such as riboflavin
synthetase gene RIBO [17] in order to resolve the misiden-
tification. Some recent studies have claimed that the
matrix-assisted laser desorption ionization-time of flight
mass spectrometry (MALDI-TOF-MS) is advantageous
over previous approaches for reliable identification of
clinically important NAC and non-Candida yeast species
[28,31,33,34]. Unfortunately, MALDI-TOF-MS requires
reference spectra of accurately identified closely related
strains otherwise the results may be erroneous. On the
other hand, the sequence-based studies have considered
the ITS1-5.8S-ITS2 region as universal DNA barcode for
yeast identification [35] and the RFLP of ITS1-5.8S-ITS2
region has successfully separated the closely related spe-
cies in the genera Candida and Pichia [36,37]. Therefore,
in this study, we targeted the ITS1-5.8S-ITS2 region to de-
velop a simple RFLP method for accurate taxonomic as-
signment of M. guilliermondii and M. caribbica.
With this background, the aim of the present study was
(i) to perform in silico prediction of restriction enzymes to
discriminate M. guilliermondii and M. caribbica using the
publicly available ITS1-5.8S-ITS2 sequences, (ii) to eva-
luate the selected enzymes by in vitro ITS-RFLP analysis
of ambiguously identified 55 yeast isolates for species-
specific taxonomic assignment, and (iii) to validate the
taxonomic assignment by ITS1-5.8S-ITS2 sequencing,
mitochondrial DNA (mtDNA)-RFLP and pulsed field gel
electrophoresis (PFGE) karyotyping.
Methods
Yeast isolates and strains
The yeast isolates used in the present study are listed in
Additional file 1: Table S1. These isolates were obtained
from samples collected at different stages of indigenous
bamboo shoot fermentation for the production of soibum
in Manipur state of North East India [38]. The sample
(10 g) was homogenized in 90 mL of sterile physio-
logical saline (1 g/L bacteriological peptone, 8.5 g/L
NaCl, pH 6.1) using Stomacher® 400 Circulator (Seward,
Worthing, West Sussex) at 250 rpm for 3 min. The
yeasts were isolated by serial dilution spread-plating of
the above homogenate on yeast extract peptone dex-
trose (YEPD) agar medium (pH 6.5) (HiMedia, Mumbai,
India) containing 100 μg/mL each of filter-sterilized
ampicillin and tetracycline (Sigma-Aldrich, Bangalore,
India), followed by incubation at 30°C for 48 − 72 h
under aerobic conditions. All the isolates were purified
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preserved at −80°C in YEPD broth containing 10% (v/v)
sterile glycerol (Sigma-Aldrich). For short term storage,
the cultures were maintained at 4°C on YEPD agar.
The type strain C. guilliermondii ATCC 6260 used for
comparison was obtained from American Type Culture
Collection.
Phenotypic characterization and morphological
observation
Phenotypic identification of the yeast isolates was carried
out using the API 20 C AUX yeast identification system
(bioMérieux, New Delhi, India) following manufacturer’s
instructions. Colony and cell morphology of the isolates
were studied using SZ-PT stereo binocular microscope
(Olympus, Japan) and BX61 phase contrast microscope
(Olympus).
In silico analysis and restriction enzyme selection
The full length ITS1-5.8S-ITS2 sequences of M. guillier-
mondii and M. caribbica were retrieved from NCBI
(http://www.ncbi.nlm.nih.gov/) and Centraalbureau voor
Schimmelcultures (CBS-KNAW) yeast nucleotide data-
bases (http://www.cbs.knaw.nl/Collections/Biolomics.aspx?
Table = CBS + strain + database). Type strain sequences of
the two species, C. guilliermondii ATCC 6260 [GenBank:
AY939792.1] and M. caribbica CBS 9966 (http://www.cbs.
knaw.nl/Collections/BioloMICS.aspx?Link =T&TargetKey =
14682616000000137&Rec = 36291&Revert = F) were sub-
jected to in silico PCR amplification using primers ITS1
(5′-TCCGTAGGTGAACCTGCGG-3′) and ITS4 (5′-TC
CTCCGCTTATTGATATGC-3′) [39] to trim off the un-
targeted regions on both 5′ and 3′ ends of the sequences
using the online Sequence Manipulation Suite (http://www.
bioinformatics.org/sms2/pcr_products). Using NEBcutter,
version 2.0 (http://tools.neb.com/NEBcutter2/), the ITS
amplicon sequences were subjected to in silico restriction
digestion using the commercially available type-II restric-
tion endonucleases listed in the REBASE database (http://
rebase.neb.com/) [40] to select the enzymes which cut the
two sequences differently at not more than 5 cleavage
sites. Multiple sequence alignment of 10 additional ITS1-
5.8S-ITS2 sequences of different strains from different
ecological niches for each species was performed using
Clustal X, version 2.0 (http://www.clustal.org/clustal2/)
and BioEdit, version 7.2.0 (http://www.mbio.ncsu.edu/
bioedit/bioedit.html) to confirm the taxa-specificity of the
selected restriction enzymes.
DNA extraction
DNA was extracted from pure cultures as cell-free DNA
lysate using lyticase-heat lysis method. Briefly, a single
colony of 24 − 48 h old culture from YEPD agar was in-
oculated to 5 mL of YEPD broth supplemented withantibiotics, and incubated for 18 h at 30°C with shaking
at 200 rpm. Cells were harvested from 1 mL of the cul-
ture broth at 5,000 g for 5 min (FA-45-24-11, Centrifuge
5424, Eppendorf, Hamburg, Germany). The cell pellet
was washed twice with 1 mL sterile 0.5 M NaCl followed
by sterile deionized water (Milli Q, Millipore, Molsheim,
France). The cells were finally resuspended in 500 μL of
1× TE buffer (10 mM Tris-Cl, 1 mM EDTA, pH 8.0)
containing 10 μL of lyticase (5U/μL) (Sigma-Aldrich)
and incubated at 37°C for 1 h. After the incubation, the
spheroplasts were lysed by heating at 95°C for 20 min.
The crude cell-free lysate was collected by centrifugation
at 10,000 g for 10 min at 4°C and the DNA was quanti-
fied spectrophotometrically (Nanodrop ND-1000, Nano-
Drop Technologies, Inc., Rockland, USA). The cell-free
lysate with absorbance ratio (A260/280) of 1.8 − 2.2 was
used for PCR analysis and stored at −20°C until
required.
ITS-RFLP
ITS1-5.8S-ITS2 was amplified from the cell-free DNA
lysate using primers ITS1 and ITS4 mentioned else-
where. The amplification was carried out in a 25 μL final
reaction volume containing 50 ng of the genomic DNA
as previously described [41]. The amplified ITS fragment
was analyzed by 2.0% (w/v) agarose gel electrophoresis
at 80 V in 0.5× TBE (45 mM Tris-borate, 1 mM EDTA,
pH 8.0) buffer to check its intactness and absence of
non-specific amplification. The PCR product (4 μL) was
digested with 5 U of TaqI (Promega, Madison, USA) in a
10 μL reaction volume at 65°C as per manufacturer’s in-
structions. The restriction patterns were analyzed by
electrophoresis of the 10 μL reaction volume on 2.0%
(w/v) agarose gel in parallel with PCR 100 bp Low DNA
ladder (Sigma-Aldrich) as molecular size standard. The
electrophoresis was run at 80 V for 2 h in 0.5× TBE buf-
fer. The gel was then stained in 0.5 μg/mL ethidium
bromide solution for 30 min with rocking at 15 rpm
on a platform rocker (Tarsons, Kolkata, India). After
destaining for 30 min in sterile deionized water, the gel
was photographed using ChemiDoc MP gel documenta-
tion system (Bio Rad, Hercules, USA). The restriction
fingerprints were analysed for the absence or presence
of discriminating fragments using GelCompar II soft-
ware, version 6.5 (Applied Maths, Sint-Martens-Latem,
Belgium).
mtDNA-RFLP
A single colony of 24 − 48 h old culture from YEPD agar
was inoculated to 5 mL of YEPD broth supplemented
with antibiotics, and incubated for 18 h at 30°C with
shaking at 200 rpm. The grown culture was inoculated
into 50 mL of fresh YEPD broth (initial OD600 = 0.1) and
incubated in the above conditions till mid-logarithmic
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were harvested at 1,800 g for 5 min at 4°C (A-4-81, Cen-
trifuge 5810R, Eppendorf ). The mtDNA was extracted
as previously described [42] with some modifications.
The cells were resuspended and washed with 5 mL of
yeast resuspension buffer (50 mM Tris-Cl, 20 mM
EDTA, pH 8.0) and stored at −20°C for 10 min. Lyticase
(50 U) (Sigma-Aldrich) was used to produce spheroplast
and 15 μL of 1 mg/mL RNase A solution (Sigma-
Aldrich) was added during cell lysis. The total DNA was
precipitated at −20°C for 1 h. After quantifying the DNA
content spectrophotometrically, the DNA was freeze
dried, re-dissolved in sterile deionized water to a final
concentration of 1 μg/μL and stored at −20°C till further
use. Restriction digestion was carried out on 10 μg of
the DNA in a 20 μL reaction volume using 10 U each of
HaeIII and HinfI (Promega) according to manufacturer’s
instructions. The restriction patterns were generated by
1.0% (w/v) agarose gel electrophoresis of the 20 μL reac-
tion volume at 80 V in 0.5× TBE buffer for 4 h in paral-
lel with 1 kb DNA ladder (Promega). After staining and
documentation, the restriction fingerprints were sub-
jected to cluster analysis using unweighted pair group
method with arithmetic mean (UPGMA) algorithm on
Jaccard similarity coefficients using GelCompar II. Com-
posite data set of the restriction digestion profiles was
generated with 1.0% position tolerance to generate the
clustering. Bootstrap analysis with 1,000 replicates was
performed to indicate the branch quality.
Electrophoretic karyotyping
Intact chromosomal DNA for electrophoretic karyotyping
using PFGE was prepared as previously described [32].
The electrophoresis was carried out in 1.0% (w/v) PFGE-
grade agarose gel (Sigma-Aldrich) and 0.5× TBE buffer at
13 − 14°C and 150 V in contour-clamped homogeneous
electric field electrophoresis apparatus (Gene Navigator,
Amersham Biosciences, Uppsala, Sweden). The gel was
run for 22 h with a switch interval of 90 s for 8 h followed
by 105 s for 6 h and finally 120 s for 8 h in parallel with
PFGE marker (225 − 22,000 kb) from Saccharomyces cere-
visiae strain YPH80 (Sigma-Aldrich). Staining and docu-
mentation were performed as mentioned elsewhere.
ITS and D1/D2 sequencing and sequence analysis
The representative isolates from each ITS-RFLP genotype
group were randomly selected for sequencing ITS1-5.8S-
ITS2 and LSU rRNA gene D1/D2 domain. ITS1-5.8S-ITS2
was PCR amplified as mentioned elsewhere. Amplification
of D1/D2 region was carried out using primers NL1
(5′-GCATATCAATAAGCGGAGGAAAAG-3′) and NL4
(5′-GGTCCGTGTTTCAAGACGG-3′) as previously de-
scribed [43]. The amplified products were purified using
NucleoSpin® Extract II gel extraction kit (Machery-Nagel,Düren, Germany) following manufacturer’s instructions.
The PCR products were sequenced using ABI 3100 Gen-
etic Analyser (Merck, Bangalore, India) with the same
primers used for the amplification. The sequence reads
were validated by analysing the electropherogram data
using ChromasLITE software, version 2.01 (http://techne-
lysium.com.au/). To identify the closest known relatives,
the sequences were queried with NCBI and CBS yeast nu-
cleotide databases. The sequences obtained from both se-
quencing and nucleotide databases were aligned using
Clustal X algorithm and a neighbour joining tree was con-
structed by Kimura’s evolutionary distance matrix obtained
from the multiple sequence alignment using MEGA4
phylogenetic software. Bootstrap values for 1000 replicates
were shown at the node of cluster branch. The sequences
were deposited to NCBI GenBank under the following
accession numbers: JF439366 − JF439369 and KF268351 −
KF268354.
Results
In silico selection of differentiating restriction enzymes
The full length ITS1-5.8S-ITS2 sequences of M. guillier-
mondii and M. caribbica were retrieved from NCBI and
CBS yeast nucleotide databases and subjected to mul-
tiple sequence alignment followed by in silico restriction
digestion. Three variable regions differentiating M. guil-
liermondii from M. caribbica were identified. Seven re-
striction enzymes (ArsI, BfaI, BsrI, Hpy188I, HpyCH4III,
MmeI and TaqI) which cut the variable regions differ-
ently were identified (Figure 1A and Additional file 2:
Figure S2). Considering the length and the number of
polymorphic fragments with sizes greater than 100 bp
(for easy analysis in normal agarose gel), BfaI, MmeI and
TaqI were found appropriate. Notably, commonly avail-
able TaqI gave distinct species-specific differentiation be-
tween the two species (Additional file 1: Table S4 and
Additional file 2: Figure S3). We also tested the selected
three restriction enzymes (BfaI, MmeI and TaqI) for dif-
ferentiating M. guilliermondii and M. caribbica from
other closely related members of M. guilliermondii com-
plex (Additional file 1: Table S4). Except C. carpophila
and M. caribbica, all other members of M. guilliermon-
dii complex were distinctly differentiated during the
analysis.
Evaluation of in silico selected restriction enzymes by
in vitro ITS-RFLP
To validate the above in silico selection, the 55 yeast iso-
lates of M. guilliermondii complex (which were not dif-
ferentiated by phenotypic characterization and D1/D2
sequencing) were analysed by ITS-RFLP using the se-
lected TaqI restriction enzyme in comparison with the
type strain C. guilliermondii ATCC 6260. All the tested
isolates and the type strain gave a single PCR amplicon
Figure 1 Differentiation of M. guilliermondii and M. caribbica by TaqI digestion of ITS1-5.8S-ITS2. A: Multiple sequence alignment of
representative ITS1-5.8S-ITS2 sequences of the two species obtained from NCBI GenBank and CBS yeast database showing position of TaqI
recognition site (highlighted) which distinctly differentiated the two species. B: TaqI restriction digestion profile of ITS1-5.8S-ITS2 amplicons
obtained from some of the representative isolates. Lane 1: C. guilliermondii ATCC 6260; Lane 2 − 12: isolates of M. guilliermondii genotype group
MG (A1S10Y1, A2S10Y1, A3S9Y1, A2S9Y1, A3S11Y1, A3S2Y1, A3S6Y1, A2S6Y1, A1S9Y1, Kw3S3Y1 and Kw2S11Y2); Lane 13 – 20: isolates of
M. caribbica genotype group MC (A1S10Y2a, A1S10Y3, A1S10Y5, Kw3S2Y1, Kw2S3Y1, Kw3S3Y3, Kw3S3Y4 and Kw1S7Y2); Lane M: PCR 100 bp
Low DNA ladder (Sigma-Aldrich).
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analysis, TaqI ITS-RFLP distinctly differentiated the iso-
lates into two genotype groups. Forty seven isolates pro-
duced M. guilliermondii-specific pattern (MG), while the
remaining eight isolates generated M. caribbica-specific
pattern (MC) (Table 1). Examples of TaqI ITS-RFLP
profiles differentiating the above two species are shown
in Figure 1B.
Validation of ITS-RFLP assay
The above ITS-RFLP based discrimination of M. guillier-
mondii and M. caribbica was further confirmed by
ITS1-5.8S-ITS2 sequencing, mtDNA-RFLP fingerprint-
ing and PFGE karyotyping (Table 1). The ITS sequences
of the isolates in each genotype group MG and MCmatched with the sequences of the type strains C. guil-
liermondii ATCC 6260 and M. caribbica CBS 9966 with
99.6% and 99.8% similarity respectively. The sequences
between the two groups were 99% identical showing
only 5 nucleotide differences which were the same as
shown by the above type strain sequences. Unlike D1/
D2 region, the ITS sequences formed distinct cluster of
M. guilliermondii and M. caribbica during phylogenetic
analysis (Figure 2). The ITS sequences of M. guillier-
mondii strains PX-PAT, CanR-56 and SD 337; M. carib-
bica strains UCLM 44A and IWBT-Y836 showed 1 – 3
nucleotide differences which was reflected as divergence
within the clusters. The mean evolutionary divergence of
0.0131 between the two clusters was 6 times more than
the divergence within each cluster.
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regated the yeast isolates into M. guilliermondii and M.
caribbica. mtDNA-RFLP profile-based dendrogram formed
two clusters (Figure 3) similar to the ITS-RFLP groups.
Between the two enzymes used, HinfI showed higher poly-
morphism than HaeIII. Electrophoretic karyotyping also
distinctly discriminated the above two species (Figure 4).
The species-specific mtDNA-RFLP pattern suggested that
the isolates of each group belonged to only one strain
(Figure 3). Whereas electrophoretic karyotyping brought
out strain level diversity in both the groups which con-
firmed that multiple strains of M. guilliermondii andFigure 2 Neighbour-joining (NJ) phylogenetic tree showing taxa-spec
constructed based on the evolutionary distance calculated using Kimura-2
percentage of replicate trees in which the associated taxa clustered togeth
for values >40%. The bar represents 1% sequence divergence. GenBank acc
was the outgroup in the analysis. T = Type strain.M. caribbica were involved in the indigenous bamboo shoot
fermentation (Figure 4 and Additional file 2: Figure S4).Discussion
In recent times, the frequency of emerging infectious
diseases caused by the opportunistic yeast species of
NAC and non-Candida groups has increased in im-
munosuppressed patients [12,44]. This is linked with the
indiscriminate use of broad-spectrum antifungal drugs
and global climate change [45-47]. Most of these closely
related yeast species are often misidentified by theific separation of M. guilliermondii from M. caribbica. The tree was
parameter from the nucleotide sequence of ITS1-5.8S-ITS2. The
er in the bootstrap test (1000 replicates) is shown next to the branches
ession numbers are mentioned within the parentheses. S. cerevisiae
Figure 3 mtDNA-RFLP based dendrogram showing distinct clustering of M. guilliermondii and M. caribbica. The dendrogram was
constructed using UPGMA algorithm on Jaccard similarity coefficients generated from HaeIII and HinfI restriction digestion profile of mtDNA of
some of the representative isolates. Value at each branch node indicates the branch quality with 1000 bootstrap replications. The scale represents
the similarity.
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ceptibility methods. Thus, accurate identification of
these species has become essential for clinical manage-
ment and effective antifungal therapy.
In the present study, we showed that the developed ITS-
RFLP method was reliable and consistent for distinct dif-
ferentiation of closely related M. guilliermondii from M.
caribbica for which phenotypic methods and D1/D2 se-
quencing were inconclusive. Our results also indicated
that sequencing of both D1/D2 and ITS regions will in-
crease the resolution of species identification which can be
further improved by multigene sequence-based phylo-
genetic approach [3,48,49]. However, the presence of
incorrectly identified, insufficiently annotated and non-
updated entries in the public nucleotide databases mayFigure 4 PFGE karyotype patterns of isolates belonging to M.
guilliermondii and M. caribbica genotype groups. Lane 1: C.
guilliermondii ATCC 6260; Lane 2 − 3: M. guilliermondii isolates
A1S10Y1 and Kw2S11Y2; Lane 4 − 11: M. caribbica isolates A1S10Y2a,
A1S10Y3, A1S10Y5, Kw3S2Y1, Kw2S3Y1, Kw3S3Y3, Kw3S3Y4 and
Kw1S7Y2; Lane M: S. cerevisiae PFGE marker (Sigma-Aldrich). Right
arrow indicates the co-migrating chromosomal doublets showing
strain level diversity.underestimate the resolving power of these taxonomic
markers [50]. Out of the 29 sequences of LSU rRNA gene
for M. guilliermondii available in NCBI GenBank, 17
sequences (58.62%) clustered with M. caribbica type
strain CBS 9966 [GenBank: EU348786] (Additional file 2:
Figure S1).
The choice of appropriate restriction endonucleases is
critical for RFLP experiments. The commonly used CfoI,
HaeIII and HinfI [37,41] failed to segregate M. guillier-
mondii from other species of the same genus during in
silico and in vitro ITS-RFLP analysis. Our results indi-
cated that in silico selection of restriction enzymes using
the publicly available sequences from various strains of
the target species is a better approach than randomly
selecting the previously described and commonly used
enzymes. This approach has been proven to be highly ef-
fective and reproducible [36,51-53], and many online re-
sources have been developed for this purpose [54-57].
Clinical isolates of Candida famata and Candida pal-
mioleophila were also frequently misidentified as M.
guilliermondii [30,31]. In silico analysis confirmed that
the developed ITS-RFLP method can also discriminate
these species (data not shown). This in silico selection
approach can be effectively applied to other cryptic yeast
species of clinical importance for the development of
RFLP based diagnostic tools.
The developed method of ITS-RFLP using TaqI differ-
entiated M. guilliermondii and M. caribbica at species
level. This method is simple, rapid and reliable in com-
parison to the commonly used sequencing methods. The
entire analysis starting from DNA extraction to ITS-
RFLP profiling can be completed within 8 h. Further
studies using higher number of strains of these two
species from different clinical sources are required to
confirm the robustness of this method for diagnostic
applications. Though the combination of ITS-RFLP
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other closely related species of the M. guilliermondii
complex from M. guilliermondii and M. caribbica during
in silico analysis, it is yet to be confirmed through
in vitro analysis using reference strains.
In our present study the use of either HaeIII or HinfI for
mtDNA-RFLP was sufficient to differentiate the two spe-
cies, but failed to give strain level differentiation even
when both enzymes were used. This demonstrated that
mtDNA-RFLP can also be used for distinct differentiation
of closely related species. The HinfI mtDNA-RFLP pattern
of our M. guilliermondii isolates was similar with the
mtDNA restriction pattern ‘E’ of M. guilliermondii strains
isolated from wineries in Alentejo, Portugal [58]. This
genotype was linked with the production of flavour com-
pound, 4-ethylphenol in wine. The major phenolic flavour
compound (4-methylphenol) detected from fermented
bamboo shoot product, soibum (Singh NR: unpublished
observations) might also have originated from M. guillier-
mondii. Future study is required to characterize the
flavour compound producing strain for starter culture de-
velopment. Though fresh bamboo shoots are highly per-
ishable, the fermented bamboo shoot can be preserved up
to one year after fermentation without any deterioration
or change in its organoleptic character. This long term
preservation may be linked with the dominant presence of
M. guilliermondii which has been reported as an efficient
biological control agent [24,25]. Being an emerging infec-
tious yeast, the presence of M. guilliermondii in fermented
food is a great concern regarding the safety of its con-
sumption. Further study in strain level is required to
unravel the pathogenic potential of M. guilliermondii asso-
ciated with soibum fermentation.
Conclusions
In this study, we described an ITS-RFLP method devel-
oped through an integrated approach of in silico selection
of restriction enzymes and in vitro validations for distinct
differentiation of frequently misidentified M. guilliermon-
dii from M. caribbica, which can be used as an alternative
or an adjunct to ITS sequencing. This method may be
used for rapid and accurate identification of emerging in-
fectious yeasts of the Saccharomycotina CTG clade. This
approach can also be used for other closely related species
complex when phenotypic methods and D1/D2 sequen-
cing are ambiguous.
Additional files
Additional file 1: Table S1. List of the 55 yeast isolates used in the
present study. Table S2. Carbon substrate assimilation pattern of
representative strains of M. guilliermondii complex using API 20 C AUX
yeast identification system. Table S3. Taxonomic assignment of isolates
belonging to M. guilliermondii complex by sequencing of LSU rRNA geneD1/D2 domain. Table S4. List of the selected type-II restriction
endonucleases that differentiated M. guilliermondii from M. caribbica and
other species of M. guilliermondii complex during in silico restriction
digestion of the ITS1-5.8S-ITS2 amplicon sequences.
Additional file 2: Figure S1. Neighbour-joining phylogenetic tree
based on LSU rRNA gene D1/D2 sequences showing taxa-nonspecific
segregation of M. guilliermondii strains. The tree was constructed based
on the evolutionary distance calculated using Kimura-2 parameter from
the representative nucleotide sequences of M. guilliermondii and M.
caribbica (position 13 to 308 of LSU rRNA gene of S. cerevisiae CBS 1171,
GenBank Accession No. AY048154.1). The percentage of replicate trees in
which the associated taxa clustered together in the bootstrap test (1000
replicates) is shown next to the branches. The bar represents 1%
sequence divergence. GenBank accession numbers are mentioned within
the parentheses. S. cerevisiae was the outgroup in the analysis. T = Type
strain. Figure S2. In silico identified restriction enzymes which distinctly
differentiated M. guilliermondii from M. caribbica. Multiple sequence
alignment of representative ITS1-5.8S-ITS2 sequences of various strains of
the two species obtained from NCBI GenBank and CBS yeast database
showing position of identified ArsI (A), BfaI (B), BsrI (C), Hpy188I (D),
HpyCH4III (E), and MmeI (F) restriction recognition sites (highlighted)
which distinctly differentiated the two species. The nucleotide position
was based on the sequence of the in silico PCR amplicon of ITS1-5.8S-
ITS2 of S. cerevisiae strain S288c (NC_001144) including gaps generated
during multiple sequence alignment. C. fermentati is the anamorph of
M. caribbica. T = Type strain. Figure S3. In silico restriction digestion
profile of M. guilliermondii and M. caribbica ITS1-5.8S-ITS2 amplicon. The
theoretical restriction digestion profile was generated using NEBcutter,
version 2.0 (http://tools.neb.com/NEBcutter2/). Lane G: M. guilliermondii
ATCC 6260; Lane C: M. caribbica CBS 9966; Lane M: 100 bp DNA ladder.
Figure S4. Strain level diversity of M. guilliermondii revealed by PFGE
karyotyping. Lane 1 − 13: Isolates A3S2Y1, Kw1S2Y1, Kw3S3Y1, A3S6Y1,
A2S6Y1, A1S9Y1, A1S9Y5, A2S9Y1, A3S9Y1, A3S9Y9, A2S10Y1, A2S10Y4
and A3S11Y1. White arrow indicates the polymorphic chromosomal
band.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
WR and KJ conceived and designed the study, carried out the analysis and
interpretation of the data and drafted the manuscript. WR carried out the
molecular studies, performed the phenotypic identification and executed the
in silico and sequence analyses. SK contributed to the molecular studies. GA
and KJ critically revised the draft manuscript. All authors read and approved
the final manuscript.
Acknowledgements
The research was supported by the Department of Biotechnology (DBT),
Govt. of India funded project (BT/PR-9268/FNS/20/342/2007). Wahengbam
Romi is a recipient of Senior Research Fellowship from Council of Scientific
and Industrial Research (CSIR), Govt. of India (112417/2 K10/1). We are
grateful to Prof. N. Rajmuhon Singh for providing the data of flavour
compounds associated with soibum. The authors would like to thank the
indigenous producers of soibum in Andro and Kwatha villages, Manipur,
India for their support during sample collection.
Author details
1Microbial Resources Division, Institute of Bioresources and Sustainable
Development (IBSD), Takyelpat Institutional Area, Imphal 795001,
Manipur, India. 2Department of Biotechnology, Gauhati University, Guwahati
781014, Assam, India.
Received: 30 July 2013 Accepted: 24 February 2014
Published: 28 February 2014
References
1. Dujon B: Yeast evolutionary genomics. Nat Rev Genet 2010, 11:512–524.
2. Lachance MA, Boekhout T, Scorzetti G, Fell JW, Kurtzman CP: Candida
Berkhout (1923). In The Yeasts: A Taxonomic Study, Volume 2. 5th edition.
Romi et al. BMC Microbiology 2014, 14:52 Page 9 of 10
http://www.biomedcentral.com/1471-2180/14/52Edited by Kurtzman CP, Fell JW, Boekhout T. San Diego: Elsevier;
2011:987–1278.
3. Lan L, Xu J: Multiple gene genealogical analyses suggest divergence and
recent clonal dispersal in the opportunistic human pathogen Candida
guilliermondii. Microbiology 2006, 152:1539–1549.
4. San Millan RM, Wu LC, Salkin IF, Lehmann PF: Clinical isolates of Candida
guilliermondii include Candida fermentati. Int J Syst Bacteriol 1997,
47:385–393.
5. Suh SO, Blackwell M: Three new beetle-associated yeast species in the
Pichia guilliermondii clade. FEMS Yeast Res 2004, 5:87–95.
6. Vaughan-Martini A, Kurtzman CP, Meyer SA, O’Neill EB: Two new species in
the Pichia guilliermondii clade: Pichia caribbica sp. nov., the ascosporic
state of Candida fermentati, and Candida carpophila comb. nov.
FEMS Yeast Res 2005, 5:463–469.
7. Kam AP, Xu J: Diversity of commensal yeasts within and among healthy
hosts. Diagn Microbiol Infect Dis 2002, 43:19–28.
8. Xu J, Mitchell TG: Geographical differences in human oral yeast flora.
Clin Infect Dis 2003, 36:221–224.
9. Krcmery V, Barnes AJ: Non-albicans Candida spp. causing fungaemia:
pathogenicity and antifungal resistance. J Hosp Infect 2002, 50:243–260.
10. Savini V, Catavitello C, Onofrillo D, Masciarelli G, Astolfi D, Balbinot A, Febbo
F, D’Amario C, D’Antonio D: What do we know about Candida
guilliermondii? A voyage throughout past and current literature about
this emerging yeast. Mycoses 2011, 54:434–441.
11. Papon N, Savini V, Lanoue A, Simkin AJ, Creche J, Giglioli-Guivarc’h N, Clastre
M, Courdavault V, Sibirny AA: Candida guilliermondii: biotechnological
applications, perspectives for biological control, emerging clinical
importance and recent advances in genetics. Curr Genet 2013 (in press)
(doi:10.1007/s00294-013-0391-0).
12. Miceli MH, Diaz JA, Lee SA: Emerging opportunistic yeast infections.
Lancet Infect Dis 2011, 11:142–151.
13. Neppelenbroek K, Seo R, Urban V, Silva S, Dovigo L, Jorge J, Campanha N:
Identification of Candida species in the clinical laboratory: a review of
conventional, commercial, and molecular techniques. Oral Dis 2013
(in press) (doi:10.1111/odi.12123).
14. Sandven P: Epidemiology of candidemia. Rev Iberoam Micol 2000, 17:73–81.
15. Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Ellis D, Tullio V, Rodloff A, Fu
W, Ling TA: Results from the ARTEMIS DISK Global Antifungal
Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities
of Candida species to fluconazole and voriconazole as determined by
CLSI standardized disk diffusion. J Clin Microbiol 2010, 48:1366–1377.
16. Chen CY, Huang SY, Tang JL, Tsay W, Yao M, Ko BS, Chou WC, Tien HF,
Hsueh PR: Clinical features of patients with infections caused by Candida
guilliermondii and Candida fermentati and antifungal susceptibility of the
isolates at a medical centre in Taiwan, 2001-10. J Antimicrob Chemother
2013 (in press) (doi:10.1093/jac/dkt214).
17. Lockhart SR, Messer SA, Pfaller MA, Diekema DJ: Identification and
susceptibility profile of Candida fermentati from a worldwide collection
of Candida guilliermondii clinical isolates. J Clin Microbiol 2009, 47:242–244.
18. Daniel HM, Vrancken G, Takrama JF, Camu N, de Vos P, de Vuyst L: Yeast
diversity of Ghanaian cocoa bean heap fermentations. FEMS Yeast Res
2009, 9:774–783.
19. Hidalgo C, Mateo E, Mas A, Torija MJ: Identification of yeast and acetic
acid bacteria isolated from the fermentation and acetification of
persimmon (Diospyros kaki). Food Microbiol 2012, 30:98–104.
20. Nova MX, Schuler AR, Brasileiro BT, Morais MA Jr: Yeast species involved in
artisanal cachaca fermentation in three stills with different technological
levels in Pernambuco, Brazil. Food Microbiol 2009, 26:460–466.
21. Wah TT, Walaisri S, Assavanig A, Niamsiri N, Lertsiri S: Co-culturing of Pichia
guilliermondii enhanced volatile flavor compound formation by
Zygosaccharomyces rouxii in the model system of Thai soy sauce
fermentation. Int J Food Microbiol 2013, 160:282–289.
22. Kim WC, So JH, Kim SI, Shin JH, Song KS, Yu CB, Kho YH, Rhee IK: Isolation,
identification, and characterization of Pichia guilliermondii K123-1 and
Candida fermentati SI, producing isoflavone β-glycosidase to hydrolyze
isoflavone glycoside efficiently, from the korean traditional soybean
paste. J Appl Biol Chem 2009, 52:163–169.
23. Boretsky YR, Pynyaha YV, Boretsky VY, Fedorovych DV, Fayura LR, Protchenko O,
Philpott CC, Sibirny AA: Identification of the genes affecting the regulation
of riboflavin synthesis in the flavinogenic yeast Pichia guilliermondii using
insertion mutagenesis. FEMS Yeast Res 2011, 11:307–314.24. Wilson CL, Chalutz E: Pichia guilliermondii (anamorph Candida
guilliermondii) useful for the biological control of postharvest rots in
fruits. US Patent 1991, 8:5041384.
25. Lima JR, Gondime DMF, Oliveirab JTA, Oliveirad FSA, Gonçalvesc LRB, Viana
FMP: Use of killer yeast in the management of postharvest papaya
anthracnose. Postharvest Biol Technol 2013, 83:58–64.
26. Cao J, Zhang H, Yang Q, Ren R: Efficacy of Pichia caribbica in controlling
blue mold rot and patulin degradation in apples. Int J Food Microbiol
2013, 162:167–173.
27. Pincus DH, Orenga S, Chatellier S: Yeast identification−past, present, and
future methods. Med Mycol 2007, 45:97–121.
28. Castanheira M, Woosley LN, Diekema DJ, Jones RN, Pfaller MA: Candida
guilliermondii and other species of Candida misidentified as Candida
famata: assessment by Vitek 2, DNA sequencing analysis, and
matrix-assisted laser desorption ionization-time of flight mass
spectrometry in two global antifungal surveillance programs.
J Clin Microbiol 2013, 51:117–124.
29. Cornet M, Sendid B, Fradin C, Gaillardin C, Poulain D, Nguyen HV: Molecular
identification of closely related Candida species using two ribosomal
intergenic spacer fingerprinting methods. J Mol Diagn 2011, 13:12–22.
30. Desnos-Ollivier M, Ragon M, Robert V, Raoux D, Gantier JC, Dromer F:
Debaryomyces hansenii (Candida famata), a rare human fungal pathogen
often misidentified as Pichia guilliermondii (Candida guilliermondii).
J Clin Microbiol 2008, 46:3237–3242.
31. Jensen RH, Arendrup MC: Candida palmioleophila: characterization of a
previously overlooked pathogen and its unique susceptibility profile in
comparison with five related species. J Clin Microbiol 2011, 49:549–556.
32. Bai FY, Liang HY, Jia JH: Taxonomic relationships among the taxa in the
Candida guilliermondii complex, as revealed by comparative
electrophoretic karyotyping. Int J Syst Evol Microbiol 2000, 50:417–422.
33. Marklein G, Josten M, Klanke U, Muller E, Horre R, Maier T, Wenzel T, Kostrzewa
M, Bierbaum G, Hoerauf A, Sahl HG: Matrix-assisted laser desorption
ionization-time of flight mass spectrometry for fast and reliable
identification of clinical yeast isolates. J Clin Microbiol 2009, 47:2912–2917.
34. Spanu T, Posteraro B, Fiori B, D’Inzeo T, Campoli S, Ruggeri A, Tumbarello M,
Canu G, Trecarichi EM, Parisi G, Tronci M, Sanguinetti M, Fadda G: Direct
MALDI-TOF mass spectrometry assay of blood culture broths for rapid
identification of Candida species causing bloodstream infections: an
observational study in two large microbiology laboratories.
J Clin Microbiol 2012, 50:176–179.
35. Schoch CL, Seifert KA, Huhndorf S, Robert V, Spouge JL, Levesque CA, Chen
W: Nuclear ribosomal internal transcribed spacer (ITS) region as a
universal DNA barcode marker for fungi. Proc Natl Acad Sci U S A 2012,
109:6241–6246.
36. Trost A, Graf B, Eucker J, Sezer O, Possinger K, Gobel UB, Adam T:
Identification of clinically relevant yeasts by PCR/RFLP. J Microbiol
Methods 2004, 56:201–211.
37. Villa-Carvajal M, Querol A, Belloch C: Identification of species in the genus
Pichia by restriction of the internal transcribed spacers (ITS1 and ITS2)
and the 5.8S ribosomal DNA gene. Antonie Van Leeuwenhoek 2006,
90:171–181.
38. Jeyaram K, Singh TA, Romi W, Devi AR, Singh WM, Dayanidhi H, Singh NR,
Tamang JP: Traditional fermented foods of Manipur. Indian J Tradit Knowl
2009, 8:115–121.
39. White TJ, Bruns T, Lee S, Taylor J: Amplification and direct sequencing of
fungal ribosomal RNA genes for phylogenetics. In PCR Protocols: A Guide
to Methods and Applications. Edited by Innis MA, Gelfand DH, Sninsky JJ,
White TJ. New York: Academic Press Inc; 1990:315–322.
40. Roberts RJ, Vincze T, Posfai J, Macelis D: REBASE−a database for DNA
restriction and modification: enzymes, genes and genomes.
Nucleic Acids Res 2010, 38:234–236.
41. Jeyaram K, Singh WM, Capece A, Romano P: Molecular identification
of yeast species associated with ‘Hamei’−a traditional starter used
for rice wine production in Manipur, India. Int J Food Microbiol 2008,
124:115–125.
42. Querol A, Barrio E, Huerta T, Ramon D: Molecular monitoring of wine
fermentations conducted by active dry yeast strains. Appl Environ
Microbiol 1992, 58:2948–2953.
43. Kurtzman CP, Robnett CJ: Identification and phylogeny of ascomycetous
yeasts from analysis of nuclear large subunit (26S) ribosomal DNA partial
sequences. Antonie Van Leeuwenhoek 1998, 73:331–371.
Romi et al. BMC Microbiology 2014, 14:52 Page 10 of 10
http://www.biomedcentral.com/1471-2180/14/5244. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele
RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP, Walsh TJ:
Epidemiology and outcome of zygomycosis: a review of 929 reported
cases. Clin Infect Dis 2005, 41:634–653.
45. Birrenbach T, Bertschy S, Aebersold F, Mueller NJ, Achermann Y,
Muehlethaler K, Zimmerli S: Emergence of Blastoschizomyces capitatus
yeast infections, Central Europe. Emerg Infect Dis 2012, 18:98–101.
46. Garcia-Solache MA, Casadevall A: Global warming will bring new fungal
diseases for mammals. mBio 2010, 1:e00061–10.
47. Raffa RB, Eltoukhy NS, Raffa KF: Implications of climate change (global
warming) for the healthcare system. J Clin Pharm Ther 2012, 37:502–504.
48. Tavanti A, Davidson AD, Gow NA, Maiden MC, Odds FC: Candida
orthopsilosis and Candida metapsilosis spp. nov. to replace Candida
parapsilosis groups II and III. J Clin Microbiol 2005, 43:284–292.
49. Tsui CK, Daniel HM, Robert V, Meyer W: Re-examining the phylogeny of
clinically relevant Candida species and allied genera based on multigene
analyses. FEMS Yeast Res 2008, 8:651–659.
50. Nilsson RH, Ryberg M, Kristiansson E, Abarenkov K, Larsson KH, Koljalg U:
Taxonomic reliability of DNA sequences in public sequence databases: a
fungal perspective. PLoS One 2006, 1:e59.
51. Brugger SD, Frei L, Frey PM, Aebi S, Muhlemann K, Hilty M: 16S rRNA
terminal restriction fragment length polymorphism for the
characterization of the nasopharyngeal microbiota. PLoS One 2012,
7:e52241.
52. Jeyaram K, Romi W, Singh TA, Adewumi GA, Basanti K, Oguntoyinbo FA:
Distinct differentiation of closely related species of Bacillus subtilis group
with industrial importance. J Microbiol Methods 2011, 87:161–164.
53. Mirhendi H, Bruun B, Schonheyder HC, Christensen JJ, Fuursted K, Gahrn-
Hansen B, Johansen HK, Nielsen L, Knudsen JD, Arendrup MC: Molecular
screening for Candida orthopsilosis and Candida metapsilosis among Danish
Candida parapsilosis group blood culture isolates: proposal of a new RFLP
profile for differentiation. J Med Microbiol 2010, 59:414–420.
54. Bikandi J, San Millan R, Rementeria A, Garaizar J: In silico analysis of
complete bacterial genomes: PCR, AFLP-PCR and endonuclease
restriction. Bioinformatics 2004, 20:798–799.
55. Collins RE, Rocap G: REPK: an analytical web server to select restriction
endonucleases for terminal restriction fragment length polymorphism
analysis. Nucleic Acids Res 2007, 35:W58–W62.
56. Junier P, Junier T, Witzel KP: TRiFLe, a program for in silico terminal
restriction fragment length polymorphism analysis with user-defined
sequence sets. Appl Environ Microbiol 2008, 74:6452–6456.
57. Vincze T, Posfai J, Roberts RJ: NEBcutter: A program to cleave DNA with
restriction enzymes. Nucleic Acids Res 2003, 31:3688–3691.
58. Martorell P, Barata A, Malfeito-Ferreira M, Fernandez-Espinar MT, Loureiro V,
Querol A: Molecular typing of the yeast species Dekkera bruxellensis and
Pichia guilliermondii recovered from wine related sources. Int J Food
Microbiol 2006, 106:79–84.
doi:10.1186/1471-2180-14-52
Cite this article as: Romi et al.: Reliable differentiation of Meyerozyma
guilliermondii from Meyerozyma caribbica by internal transcribed spacer
restriction fingerprinting. BMC Microbiology 2014 14:52.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
